Medications for Aidsrelated Kaposi Sarcoma
8 results
Doxorubicin hydrochloride liposome (doxorubicin hydrochloride liposome)
(Doxorubicin Hydrochloride Liposome)Baxter Healthcare Corporation
Usage: Doxorubicin hydrochloride liposome injection is indicated for treating advanced ovarian cancer after platinum therapy failure, AIDS-related Kaposi’s sarcoma post-chemotherapy failure or intolerance, and multiple myeloma in combination with bortezomib in patients having received prior therapy.
Paclitaxel (paclitaxel)
(paclitaxel)Gland Pharma Limited
Usage: Paclitaxel Injection, USP is indicated for treating advanced ovarian carcinoma, node-positive breast cancer after doxorubicin, metastatic breast cancer post-chemotherapy, nonsmall cell lung cancer in inoperable patients, and second-line treatment of AIDS-related Kaposi’s sarcoma. It can be used in combination with cisplatin for specific conditions.
Paclitaxel (paclitaxel)
(Paclitaxel)Natco Pharma USA LLC
Usage: Paclitaxel Injection, USP is indicated for advanced ovarian carcinoma, adjuvant treatment of node-positive breast cancer, breast cancer after prior chemotherapy failure, first-line treatment of non-small cell lung cancer, and second-line treatment of AIDS-related Kaposi’s sarcoma.
Paclitaxel (paclitaxel)
(Paclitaxel)Alembic Pharmaceuticals Limited
Usage: Paclitaxel Injection, USP, is indicated for the treatment of advanced ovarian carcinoma, node-positive breast cancer (adjuvant), breast cancer post-chemotherapy failure, non-small cell lung cancer (first-line inoperable cases), and second-line treatment of AIDS-related Kaposi's sarcoma.
Paclitaxel (paclitaxel)
(Paclitaxel)Novadoz Pharmaceuticals LLC
Usage: Paclitaxel Injection, USP is indicated for advanced ovarian carcinoma, adjuvant node-positive breast cancer, metastatic breast cancer after chemotherapy failure, first-line treatment of non-small cell lung cancer, and second-line treatment of AIDS-related Kaposi's sarcoma. It is often used in combination with cisplatin for specific indications.
Paclitaxel (paclitaxel)
(Paclitaxel)Alembic Pharmaceuticals Inc.
Usage: Paclitaxel Injection, USP is indicated for treating advanced ovarian carcinoma, adjuvant node-positive breast cancer, breast cancer post-chemotherapy failure, non-small cell lung cancer (with cisplatin), and as second-line therapy for AIDS-related Kaposi's sarcoma.
Panretin® (alitretinoin)
(alitretinoin)Ligand Pharmaceuticals Incorporated
Usage: Panretin® gel is indicated for topical treatment of cutaneous lesions in patients with AIDS-related Kaposi’s sarcoma. It is not suitable for cases requiring systemic therapy, such as significant new lesions or symptomatic involvement.
Pomalyst (pomalidomide)
(pomalidomide)Celgene Corporation
Usage: POMALYST is indicated for adult patients with multiple myeloma who have undergone at least two prior therapies, including lenalidomide and a proteasome inhibitor, demonstrating disease progression. It is also indicated for treating AIDS-related Kaposi sarcoma after HAART failure and Kaposi sarcoma in HIV-negative adults.